scispace - formally typeset
Open AccessJournal ArticleDOI

The role of the gut microbiome in chronic liver disease: the clinical evidence revised.

TLDR
The relationship between the intestinal microbiota and liver diseases is discussed, as well as reviewing intestinal microbiota-based treatment options that are currently being investigated, and there is emerging evidence on the effects of faecal microbial transplant.
Abstract
Recent research has suggested a role for the intestinal microbiota in the pathogenesis and potential treatment of a wide range of liver diseases. The intestinal microbiota and bacterial products may contribute to the development of liver diseases through multiple mechanisms including increased intestinal permeability, chronic systemic inflammation, production of short-chain fatty acids and changes in metabolism. This suggests a potential role for pre-, pro- and synbiotic products in the prevention or treatment of some liver diseases. In addition, there is emerging evidence on the effects of faecal microbial transplant. Herein, we discuss the relationship between the intestinal microbiota and liver diseases, as well as reviewing intestinal microbiota-based treatment options that are currently being investigated.

read more

Citations
More filters
Journal ArticleDOI

Gut microbiota in human metabolic health and disease.

TL;DR: How the gut microbiota and derived microbial compounds may contribute to human metabolic health and to the pathogenesis of common metabolic diseases are discussed, and examples of microbiota-targeted interventions aiming to optimize metabolic health are highlighted.
Journal ArticleDOI

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders

TL;DR: The mechanisms that regulate intestinal permeability are reviewed and how changes in the intestinal microbiome contribute to development of acute and chronic liver diseases are discussed.
Journal ArticleDOI

Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.

TL;DR: How microbes and their products contribute to liver disease pathogenesis, putative microbial biomarkers of disease, and potential treatment approaches based on manipulation of the gut microbiota are discussed.
Journal ArticleDOI

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies

TL;DR: The processes triggering the recruitment and/or activation of hepatic innate immune cells, with a focus on macrophages, neutrophils, and innate lymphoid cells as well as the contribution of hepatocytes and endothelial cells in driving liver inflammation/fibrosis are highlighted.
References
More filters
Journal ArticleDOI

Metagenomic Analysis of the Human Distal Gut Microbiome

TL;DR: Using metabolic function analyses of identified genes, the human genome is compared with the average content of previously sequenced microbial genomes and humans are superorganisms whose metabolism represents an amalgamation of microbial and human attributes.
Related Papers (5)